Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $150.7700 (-2.7%) ($150.0400 - $155.2100) on Thu. May. 3, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.99% (three month average) | RSI | 32 | Latest Price | $150.7700(-2.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1% a day on average for past five trading days. | Weekly Trend | LGND declines -4.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(53%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -0.995% in a week (0% probabilities). TLT(-15%) VIXM(-13%) UUP(-8%) GDXJ(-7%) DIA(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.995% (StdDev 1.99%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
Resistance Level | $161.62 | 5 Day Moving Average | $155(-2.73%) | 10 Day Moving Average | $158.15(-4.67%) | 20 Day Moving Average | $161.62(-6.71%) | To recent high | -17.4% | To recent low | 0.5% | Market Cap | $2.423b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |